Logo-bi
Case Report

1. Late ventricular septal defect due to blunt trauma
Hassan Soleimanpour*, Samad Shams Vahdati, M.Bassir A.Fakhree
Bioimpacts. 2015;5(2): 93-95. doi: 10.15171/bi.2015.14
PMCID: PMC4492190     PMID: 26191503     Scopus ID: 84930411719    
Article
PDF
XML
Cited By:
0
0
0
Original Research COVID-19

2. Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Khalil Ansarin ORCID, Ramin Tolouian, Mohammadreza Ardalan* ORCID, Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri ORCID, Kenneth R. Chapman ORCID
Bioimpacts. 2020;10(4): 209-215. doi: 10.34172/bi.2020.27
PMCID: PMC7502909     PMID: 32983936     Scopus ID: 85092050012    
Article
PDF
Full Text
XML
Cited By:
85
58
89
Based on a randomized clinical trial, bromhexine is proposed as a potential therapeutic option in COVID-19. A total of 78 patients with similar demographic and disease characteristics were treated with results showing a significant reduction in ICU admissions.
Original Research

3. To detect potential pathways and target genes in infantile Pompe patients using computational analysis
Aynur Karadağ Gürel* ORCID, Selçuk Gürel ORCID
BioImpacts. 2022;12(2): 89-105. doi: 10.34172/bi.2022.23467
PMCID: PMC8905584     PMID: 35411297     Scopus ID: 85127154960    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
4
0
6
As a result, it suggests that the enriched genes and new pathways emerging as a result of the analysis may help identify the group that responds poorly to treatment and the outcome of the treatment.
Original Article

4. SBFI-26 enhances apoptosis in docetaxel-treated triple-negative breast cancer cells by increasing ROS levels
Gang He* ORCID, Mei Liu, Tang cong Chen, Li fen Huang, You qiang Ke
Bioimpacts. 2025;15: 30137 | Published on: 2024 Apr 30. doi: 10.34172/bi.30137
Article
PDF
XML
Cited By:
0
Review

5. Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia
S Rehan Ahmad* ORCID, Md Zeyaullah* ORCID, Abdullah M. AlShahrani, Mohammad Suhail Khan, Adam Dawria, Ali Mohieldin, Haroon Ali, Abdelrhman AG Altijani, Mohammad Shane Alam, Munzila Mehdi, Sabika Akram, Ejaz Rizvi Hussain, Mohammad Amjad Kamal
Bioimpacts. 2025;15: 30259 | Published on: 2024 Sep 09. doi: 10.34172/bi.30259
Article
PDF
Suppl 1
XML
Cited By:
0
Review

6. The treatment of psoriasis via herbal formulation and nano-polyherbal formulation: A new approach
Tejpal Yadav ORCID, Hemant Kumar Singh Yadav ORCID, Abhay Raizaday ORCID, Md Sabir Alam* ORCID
Bioimpacts. 2025;15: 30341 | Published on: 2024 Aug 11. doi: 10.34172/bi.30341
Article
PDF
XML
Cited By:
1
Original Article

7. Targeting hypoxia-inducible factor 1 alpha augments synergistic effects of chemo/immunotherapy via modulating tumor microenvironment in a breast cancer mouse model
Mohsen Rashid ORCID, Mina Ramezani, Ommoleila Molavi, Zeinab Ghesmati, Behzad Baradaran, Mehdi Sabzichi, Fatemeh Ramezani* ORCID
Bioimpacts. 2025;15: 30424 | Published on: 2024 Sep 10. doi: 10.34172/bi.30424
Article
PDF
XML
Cited By:
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge